“Glaucoma is a complex disease with a significant impact on millions of people around the world. Our proteomic analysis services can provide researchers with invaluable insights into the biological pathways involved in glaucoma and pave the way for new therapeutic interventions.” said the chief scientific officer at Ace Therapeutics.
Realizing the aqueous humor (AH) is a key site for studying the pathogenesis of glaucoma, Ace Therapeutics’ team of experts can conduct quantitative to detect changes in protein expression, offering valuable information for biomarker discovery and enhancing the knowledge of the molecular mechanisms of glaucoma. Additionally, the company can also provide proteomic analysis of vitreous humor (VH) services to assist researchers in discussing and expanding their findings on glaucoma.
At Ace Therapeutics, its expert team will take care of the sample preparation of different ocular tissues and biological fluids associated with glaucoma, complex analytical experiments as well as data analysis using mass spectrometry, bioinformatics, and many other advanced technologies and facilities. These services are tailored to meet the specific needs of researchers working in both academic and industry settings.Statistics: Posted by marinabarrow — Wed Nov 27, 2024 2:28 am
]]>